Ex Vivo-Activated MHC-Unrestricted Immune Effectors for Cancer Adoptive Immunotherapy

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 2, 2014-02 ,pp. : 211-222

Bentham Science Publishers

Access to resources Recommend Favorite

Dendritic cells can be rapidly expanded ex vivo and safely administered in patients with metastatic breast cancer

By Dees E.   McKinnon Karen   Kuhns Jennifer   Chwastiak Kathryn   Sparks Scotty   Myers Mary   Collins Edward   Frelinger Jeffrey   Deventer Henrik   Collichio Frances   Carey Lisa   Brecher Mark   Graham Mark   Earp H.   Serody Jonathan  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 9, 2004-09 ,pp. : 777-785

Springer Publishing Company

Access to resources Recommend Favorite

Analysis of T-cell responses in metastatic melanoma patients vaccinated with dendritic cells pulsed with tumor lysates

By Griffioen Marieke   Borghi Martina   Schrier Peter   Osanto Susanne   Schadendorf Dirk  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 8, 2004-08 ,pp. : 715-722

Springer Publishing Company

Access to resources Recommend Favorite

Telomere length of in vivo expanded CD4⁺CD25⁺ regulatory T-cells is preserved in cancer patients

By Wolf Dominik   Rumpold Holger   Koppelstätter Christian   Gastl Guenther   Steurer Michael   Mayer Gert   Gunsilius Eberhard   Tilg Herbert   Wolf Anna  

Cancer Immunology, Immunotherapy, Vol. 55, Iss. 10, 2006-10 ,pp. : 1198-1208

Springer Publishing Company

Access to resources Recommend Favorite

In vivo tracking of macrophage activated killer cells to sites of metastatic ovarian carcinoma

By Ritchie D.   Mileshkin L.   Wall D.   Bartholeyns J.   Thompson M.   Coverdale J.   Lau E.   Wong J.   Eu P.   Hicks R.   Prince H.  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 2, 2007-02 ,pp. : 155-163

Springer Publishing Company

Access to resources Recommend Favorite